Frank H. Jellinek Jr., chairman emeritus of Fisher Scientific International Inc. (NYSE: FSH), died yesterday morning in a tragic plane crash at the McClellan-Palomar Airport in Carlsbad, Calif. Jellinek, 60, is survived by his wife, Judy, two children and two grandchildren. "All of us at Fisher are deeply saddened by the loss of our good friend. Our heartfelt sympathy and prayers go out to Frank's family," said Paul M. Montrone, chairman and chief executive officer of Fisher Scientific International. "Frank was a great leader and an outstanding person who dedicated his life to his family, company and community. Everyone who knew and worked with him was impressed by his passion for the business and his warm personality. He will be greatly missed." Jellinek was appointed chairman emeritus following the 2004 merger of Apogent Technologies and Fisher Scientific International. Prior to the merger, he served as chairman and chief executive officer of Apogent Technologies. Jellinek was a veteran in the scientific-research industry with more than 40 years of experience. In 1962, at the age of 15, he began working at Erie Scientific, a microscope slide company his grandfather founded. Erie Scientific was sold to Sybron Corporation in 1969 and Jellinek remained with the company, eventually becoming president of Sybron in 1998. In 2000, Sybron changed its name to Apogent Technologies, and Jellinek was named president and CEO. Born in Buffalo, N.Y., Jellinek earned a bachelor's degree in business administration from Miami University in Ohio and an MBA from Canisius College in New York. Fisher Scientific: A World Leader in Serving Science Fisher Scientific International Inc. (NYSE: FSH) is a leading provider of products and services to the scientific community. Fisher facilitates discovery by supplying researchers and clinicians in labs around the world with the tools they need. We serve pharmaceutical and biotech companies; colleges and universities; medical-research institutions; hospitals; reference, quality-control, process-control and R&D labs in various industries; as well as government agencies. From biochemicals, cell-culture media and proprietary RNAi technology to rapid-diagnostic tests, safety products and other consumable supplies, Fisher provides more than 600,000 products and services. This broad offering, combined with Fisher's globally integrated supply chain and unmatched sales and marketing presence, helps make our 350,000 customers more efficient and effective at what they do. Founded in 1902, Fisher Scientific is a FORTUNE 500 company and is a component of the S&P 500 Index. Fisher Scientific is a company committed to high standards and delivering on our promises -- to customers, shareholders and employees alike. Additional information about Fisher is available on the company's Web site at www.fisherscientific.com.
Fisher Scientific (NYSE:FSH)
Historical Stock Chart
From Jan 2025 to Feb 2025 Click Here for more Fisher Scientific Charts.
Fisher Scientific (NYSE:FSH)
Historical Stock Chart
From Feb 2024 to Feb 2025 Click Here for more Fisher Scientific Charts.